CEOINSIDER

Company

Hims & Hers

PublicHealthcareUSA

Hims & Hers is a telehealth company that provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.

Hims & Hers is a publicly traded company operating in the healthcare sector, based in USA. Leadership tracked by CEOInsider includes Andrew Dudum (CEO).

www.hims.com ↗LinkedIn ↗

Leadership

Current

Recent developments

AI summary of recent coverage

Recent coverage of Hims & Hers has focused primarily on CEO Andrew Dudum's public statements regarding the company's strategic initiatives and regulatory challenges. The headlines highlight the CEO's discussion of upcoming artificial intelligence health coaching capabilities, expansion into peptide therapies, anticipated pricing reductions in GLP-1 medications, and his response to an FTC lawsuit regarding health data sharing practices. Additionally, coverage has touched on the CEO's substantial shareholding stake in the company and broader commentary on the firm's approach to transforming healthcare delivery.

Summarized from the headlines in the sidebar; see each source for the full story.